Mereo Biopharma Group Plc ADR (NASDAQ:MREO) price on Thursday, March 28, rose 10.00% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $3.30.
A look at the stock’s price movement, the close in the last trading session was $3.00. Turning to its 52-week performance, $4.36 and $0.69 were the 52-week high and 52-week low respectively. Overall, MREO moved -11.53% over the past month.
Mereo Biopharma Group Plc ADR’s market cap currently stands at around $462.20 million, with investors looking forward to this quarter’s earnings report slated for Mar 29, 2024 – Apr 02, 2024.
Revisions could be used as tool to get short term price movement insight, and for the company that in the past seven days was no upward and no downward review(s). Turning to the stock’s technical picture we see that short term indicators suggest on average that MREO is a Hold. On the other hand, the stock is on average a 50% Buy as suggested by medium term indicators while long term indicators are putting the stock in 100% Buy category.
MREO’s current price about -1.35% and -6.59% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 50.23, while 7-day volatility ratio is 7.34% and 6.40% in the 30-day chart. Further, Mereo Biopharma Group Plc ADR (MREO) has a beta value of 0.77, and an average true range (ATR) of 0.23.
If we refocus on Mereo Biopharma Group Plc ADR (NASDAQ:MREO), historical trading data shows that trading volumes averaged 1.19 million over the past 10 days and 1.75 million over the past 3 months. The company’s latest data on shares outstanding shows there are 140.06 million shares.
The 0.00% of Mereo Biopharma Group Plc ADR’s shares are in the hands of company insiders while institutional holders own 61.40% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 2.19 million on Mar 15, 2024, giving us a short ratio of 1.46. The data shows that as of Mar 15, 2024 short interest in Mereo Biopharma Group Plc ADR (MREO) stood at 1.56% of shares outstanding, with shares short falling to 2.78 million registered in Feb 15, 2024. Current price change has pushed the stock 42.86% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the MREO stock continues to rise going into the next quarter.
